Advanced Medical Solutions Group plc Proposes Full Year Dividend for 2019, Payable on June 19, 2020; Provides Revenue Guidance for the Year 2020
The Group expects to deliver more than 10% revenue growth in 2020 driven by new product launches, strong underlying demand for surgical portfolio and opportunities arising from the transition to MDR. US LiquiBand® is expected to return to growth in 2020 given the recent approval of LiquiBand® Rapid and the anticipated approval of LiquiBand® XL which is expected in H2.